While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
Pharma’s Diabetes War Escalates
By Dave Williamson
-
Updated Apr 7, 2017 at 12:29PM
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
NYSE: LLY
Eli Lilly and Company

Market Cap
$295B
Today's Change
(0.76%) $2.47
Current Price
$327.18
Price as of July 5, 2022, 4:00 p.m. ET
Today Fool.com health-care analysts David Williamson and Max Macaluso look at one of the largest and most profitable segments of the pharmaceutical space: diabetes treatment.
With the market growing rapidly, it's attracted a lot of attention from big pharma companies, and the pressure to improve treatments is heating up.
Merck is attempting to hold on to market share for now, but Amalin's technology has the potential to upset the standing king. Ultimately, David thinks Merck will still be able to retain its throne but recognizes that the stakes are heating up.
Stocks Mentioned

Eli Lilly and Company
LLY
$327.18
(0.76%)
$2.47

Bristol Myers Squibb Company
BMY
$75.96
(-1.15%)
$0.88

Merck & Co., Inc.
MRK
$92.64
(0.24%)
$0.22

AstraZeneca PLC
AZN
$10,986.00
(1.72%)
$186.00

Alkermes plc
ALKS
$31.43
(2.95%)
$0.90
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Our Most Popular Articles

Warren Buffett's Secret Portfolio Has 86% of Its Assets Invested In These 3 Stocks

2 FAANG Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague

Your Social Security Benefit Will Be Bigger if You Claim It at 70, But Here Are Reasons You Shouldn't Wait

2 Warren Buffett Stocks That Are Absolutely Trouncing the Stock Market
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.